Breaking News
Get 50% Off 0
📌 New AI-picked stocks coming soon. 3 picks from last month are already up +30%...
Get early access
Close

Bioage Labs Inc (BIOA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Bioage Labs's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
4.55 +0.07    +1.45%
14:54:17 - Real-time Cboe. Currency in USD
Type:  Equity
Market:  United States
  • Volume: 4,951
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 4.50 - 4.59
Bioage Labs 4.55 +0.07 +1.45%

Bioage Labs Inc Company Profile

 
Get an in-depth profile of Bioage Labs Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

63

Equity Type

ORD

BioAge Labs, Inc. is a biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets allows users to identify targets based on insights into molecular changes that drive aging. Its product includes azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults. It develops BGE-102, an orally available small molecule brain-penetrant NLRP3 antagonist for the treatment of diseases driven by neuroinflammation. The company was incorporated in 2015 and is based in Richmond, California.

Contact Information

Address 1445A South 50th Street
Richmond, 94804
United States
Phone 510 806 1445
Fax -

Top Executives

Name Age Since Title
Vijay Satyanand Pande 53 2017 Independent Director
Kristen Fortney 41 2015 Co-Founder, CEO, President, Treasurer, Secretary & Director
Eric Morgen 42 2017 Co-Founder, COO & Director
Rekha Hemrajani 55 2021 Independent Director
James Irvin Healy 59 2024 Independent Director
Patrick Gerald Enright 63 2024 Independent Director
Caroline M. Apovian - 2024 Member of Scientific Advisory Board
Michael Harvey Davidson 68 2024 Independent Director
Cedric Dray - 2024 Member of Scientific Advisory Board
Narimon Honarpour - 2024 Member of Scientific Advisory Board
Jean-Pierre Garnier 77 2024 Independent Chairman of the Board
G. Alexander Fleming - 2024 Member of Scientific Advisory Board
Melanie Haines - - Member of Scientific Advisory Board
William J. Evans - 2024 Member of Scientific Advisory Board
Timothy Rolph 70 2024 Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BIOA Comments

Write your thoughts about Bioage Labs Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email